|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:MRPL30-EIF5B (FusionGDB2 ID:54992) |
Fusion Gene Summary for MRPL30-EIF5B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MRPL30-EIF5B | Fusion gene ID: 54992 | Hgene | Tgene | Gene symbol | MRPL30 | EIF5B | Gene ID | 51263 | 9669 |
| Gene name | mitochondrial ribosomal protein L30 | eukaryotic translation initiation factor 5B | |
| Synonyms | L28MT|L30MT|MRP-L28|MRP-L30|MRPL28|MRPL28M|RPML28 | IF2 | |
| Cytomap | 2q11.2 | 2q11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 39S ribosomal protein L30, mitochondrial39S ribosomal protein L28, mitochondrialmitochondrial large ribosomal subunit protein uL30m | eukaryotic translation initiation factor 5BeIF-5Btranslation initiation factor IF-2translation initiation factor IF2 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q8TCC3 | O60841 | |
| Ensembl transtripts involved in fusion gene | ENST00000338148, ENST00000409145, ENST00000410042, ENST00000465432, | ENST00000289371, | |
| Fusion gene scores | * DoF score | 9 X 5 X 8=360 | 17 X 18 X 5=1530 |
| # samples | 9 | 21 | |
| ** MAII score | log2(9/360*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(21/1530*10)=-2.86507041991389 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: MRPL30 [Title/Abstract] AND EIF5B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | MRPL30(99804720)-EIF5B(99980734), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | EIF5B | GO:0006446 | regulation of translational initiation | 10432305 |
| Fusion gene breakpoints across MRPL30 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across EIF5B (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-HU-A4GN-01A | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + |
Top |
Fusion Gene ORF analysis for MRPL30-EIF5B |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000338148 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + |
| In-frame | ENST00000409145 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + |
| In-frame | ENST00000410042 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + |
| intron-3CDS | ENST00000465432 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000410042 | MRPL30 | chr2 | 99804720 | + | ENST00000289371 | EIF5B | chr2 | 99980734 | + | 4777 | 339 | 207 | 2864 | 885 |
| ENST00000338148 | MRPL30 | chr2 | 99804720 | + | ENST00000289371 | EIF5B | chr2 | 99980734 | + | 4768 | 330 | 198 | 2855 | 885 |
| ENST00000409145 | MRPL30 | chr2 | 99804720 | + | ENST00000289371 | EIF5B | chr2 | 99980734 | + | 4661 | 223 | 91 | 2748 | 885 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000410042 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + | 0.000116835 | 0.9998832 |
| ENST00000338148 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + | 0.000109953 | 0.9998901 |
| ENST00000409145 | ENST00000289371 | MRPL30 | chr2 | 99804720 | + | EIF5B | chr2 | 99980734 | + | 0.000107681 | 0.99989235 |
Top |
Fusion Genomic Features for MRPL30-EIF5B |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for MRPL30-EIF5B |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:99804720/chr2:99980734) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MRPL30 | EIF5B |
| FUNCTION: Plays a role in translation initiation. Translational GTPase that catalyzes the joining of the 40S and 60S subunits to form the 80S initiation complex with the initiator methionine-tRNA in the P-site base paired to the start codon. GTP binding and hydrolysis induces conformational changes in the enzyme that renders it active for productive interactions with the ribosome. The release of the enzyme after formation of the initiation complex is a prerequisite to form elongation-competent ribosomes. {ECO:0000250|UniProtKB:P39730}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 491_496 | 379 | 1221.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 529_567 | 379 | 1221.0 | Compositional bias | Note=Asp/Glu-rich (acidic) | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 629_846 | 379 | 1221.0 | Domain | tr-type G | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 638_645 | 379 | 1221.0 | Region | G1 | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 663_667 | 379 | 1221.0 | Region | G2 | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 702_705 | 379 | 1221.0 | Region | G3 | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 756_759 | 379 | 1221.0 | Region | G4 | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 824_826 | 379 | 1221.0 | Region | G5 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 138_142 | 379 | 1221.0 | Compositional bias | Note=Poly-Asp | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 313_322 | 379 | 1221.0 | Compositional bias | Note=Poly-Lys | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 353_356 | 379 | 1221.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 361_364 | 379 | 1221.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 39_50 | 379 | 1221.0 | Compositional bias | Note=Poly-Lys | |
| Tgene | EIF5B | chr2:99804720 | chr2:99980734 | ENST00000289371 | 4 | 24 | 94_99 | 379 | 1221.0 | Compositional bias | Note=Poly-Lys |
Top |
Fusion Gene Sequence for MRPL30-EIF5B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >54992_54992_1_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000338148_EIF5B_chr2_99980734_ENST00000289371_length(transcript)=4768nt_BP=330nt CTCTTTCTAGGGACTTTCCTGAGTGGGAGGGATTTCGCCGGAACAAAAATGCCTCAGTTTGGAGGTCGCGCTCACTGCGACGGCAGGCTT TGAGTGTAGCACTTGGTAGTTCTTCCTCTGCTCTGCTTCCCTTCGGAGGAAAATTTCAGGCTGAAGGTTTAGCGGGTGCCGCCTCTAAAG AGAGCAATCACTACACTTATGGCTGGGATTTTGCGCTTAGTAGTTCAATGGCCCCCAGGCAGACTACAGACTGTGACAAAAGGTGTGGAG TCTCTTATTTGTACAGATTGGATTCGTCACAAATTCACCAGATCAAGAATTCCAGAAAAAGAACGATTGGAACAAGAAAAAAGAGAAAGG AAAAAGCAAAAAGAAAAAGAAAGAAAAGAACGCTTGAAAAAAGAAGGGAAACTTTTAACTAAATCCCAGAGAGAAGCCAGAGCCAGAGCC GAAGCTACTCTTAAACTGCTACAAGCTCAGGGTGTTGAAGTGCCATCAAAAGACTCTTTGCCAAAGAAGAGGCCAATTTATGAAGATAAA AAGAGGAAAAAAATACCACAGCAGCTAGAAAGTAAAGAAGTGTCTGAATCAATGGAATTATGTGCTGCTGTAGAAGTTATGGAACAAGGA GTACCAGAAAAGGAAGAGACACCACCTCCTGTTGAACCAGAAGAAGAAGAAGATACTGAGGATGCTGGATTGGATGATTGGGAAGCTATG GCCAGTGATGAGGAGACAGAAAAAGTAGAAGGAAACAAAGTTCATATAGAAGTAAAAGAAAACCCTGAAGAGGAGGAGGAGGAGGAAGAA GAGGAAGAAGAAGATGAAGAAAGTGAAGAAGAGGAGGAAGAGGAGGGAGAAAGTGAAGGCAGTGAAGGTGATGAGGAAGATGAAAAGGTG TCAGATGAGAAGGATTCAGGGAAGACATTAGATAAAAAGCCAAGTAAAGAAATGAGCTCAGATTCTGAATATGACTCTGATGATGATCGG ACTAAAGAAGAAAGGGCTTATGACAAAGCAAAACGGAGGATTGAGAAACGGCGACTTGAACATAGTAAAAATGTAAACACCGAAAAGCTA AGAGCCCCTATTATCTGCGTACTTGGGCATGTGGACACAGGGAAGACAAAAATTCTAGATAAGCTCCGTCACACACATGTACAAGATGGT GAAGCAGGTGGTATCACACAACAAATTGGGGCCACCAATGTTCCTCTTGAAGCTATTAATGAACAGACTAAGATGATTAAAAATTTTGAT AGAGAGAATGTACGGATTCCAGGAATGCTAATTATTGATACTCCTGGGCATGAATCTTTCAGTAATCTGAGAAATAGAGGAAGCTCTCTT TGTGACATTGCCATTTTAGTTGTTGATATTATGCATGGTTTGGAGCCCCAGACAATTGAGTCTATCAACCTTCTCAAATCTAAAAAATGT CCCTTCATTGTTGCACTCAATAAGATTGATAGGTTATATGATTGGAAAAAGAGTCCTGACTCTGATGTGGCTGCTACTTTAAAGAAGCAG AAAAAGAATACAAAAGATGAATTTGAGGAGCGAGCAAAGGCTATTATTGTAGAATTTGCACAGCAGGGTTTGAATGCTGCTTTGTTTTAT GAGAATAAAGATCCCCGCACTTTTGTGTCTTTGGTACCTACCTCTGCACATACTGGTGATGGCATGGGAAGTCTGATCTACCTTCTTGTA GAGTTAACTCAGACCATGTTGAGCAAGAGACTTGCACACTGTGAAGAGCTGAGAGCACAGGTGATGGAGGTTAAAGCTCTCCCGGGGATG GGCACCACTATAGATGTCATCTTGATCAATGGGCGTTTGAAGGAAGGAGATACAATCATTGTTCCTGGAGTAGAAGGGCCCATTGTAACT CAGATTCGAGGCCTCCTGTTACCTCCTCCTATGAAGGAATTACGAGTGAAGAACCAGTATGAAAAGCATAAAGAAGTAGAAGCAGCTCAG GGGGTAAAGATTCTTGGAAAAGACCTGGAGAAAACATTGGCTGGTTTACCCCTCCTTGTGGCTTATAAAGAAGATGAAATCCCTGTTCTT AAAGATGAATTGATCCATGAGTTAAAGCAGACACTAAATGCTATCAAATTAGAAGAAAAAGGAGTCTATGTCCAGGCATCTACACTGGGT TCTTTGGAAGCTCTACTGGAATTTCTGAAAACATCAGAAGTGCCCTATGCAGGAATTAACATTGGCCCAGTGCATAAAAAAGATGTTATG AAGGCTTCAGTGATGTTGGAACATGACCCTCAGTATGCAGTAATTTTGGCCTTCGATGTGAGAATTGAACGAGATGCACAAGAAATGGCT GATAGTTTAGGAGTTAGAATTTTTAGTGCAGAAATTATTTATCATTTATTTGATGCCTTTACAAAATATAGACAAGACTACAAGAAACAG AAACAAGAAGAATTTAAGCACATAGCAGTATTTCCCTGCAAGATAAAAATCCTCCCTCAGTACATTTTTAATTCTCGAGATCCGATAGTG ATGGGGGTGACGGTGGAAGCAGGTCAGGTGAAACAGGGGACACCCATGTGTGTCCCAAGCAAAAATTTTGTTGACATCGGAATAGTAACA AGTATTGAAATAAACCATAAACAAGTGGATGTTGCAAAAAAAGGACAAGAAGTTTGTGTAAAAATAGAACCTATCCCTGGTGAGTCACCC AAAATGTTTGGAAGACATTTTGAAGCTACAGATATTCTTGTTAGTAAGATCAGCCGGCAGTCCATTGATGCACTCAAAGACTGGTTCAGA GATGAAATGCAGAAGAGTGACTGGCAGCTTATTGTGGAGCTGAAGAAAGTATTTGAAATCATCTAATTTTTTCACATGGAGCAGGAACTG GAGTAAATGCAATACTGTGTTGTAATATCCCAACAAAAATCAGACAAAAAATGGAACAGACGTATTTGGACACTGATGGACTTAAGTATG GAAGGAAGAAAAATAGGTGTATAAAATGTTTTCCATGAGAAACCAAGAAACTTACACTGGTTTGACAGTGGTCAGTTACATGTCCCCACA GTTCCAATGTGCCTGTTCACTCACCTCTCCCTTCCCCAACCCTTCTCTACTTGGCTGCTGTTTTAAAGTTTGCCCTTCCCCAAATTTGGA TTTTTATTACAGATCTAAAGCTCTTTCGATTTTATACTGATTAAATCAGTACTGCAGTATTTGATTAACCAAGCTTCTGCAGATTTTGTG ATTCTTGGGACTTTTTTGACGTAAGAAATACTTCTTTATTTATGCATATTCTTCCCACAGTGATTTTTCCAGCATTCTTCTGCCATATGC CTTTAGGGCTTTTATAAAATAGAAAATTAGGCATTCTGATATTTCTTTAGCTGCTTTGTGTGAAACCATGGTGTAAAAGCACAGCTGGCT GCTTTTTACTGCTTGTGTAGTCACGAGTCCATTGTAATCATCACAATTCTAAACCAAACTACCAATAAAGAAAACAGACATCCACCAGTA AGCAAGCTCTGTTAGGCTTCCATGTTAGTGTAGCTTCTCTCCCACAAGTTGTCCTCCTAGGACAAGAATTATCTTACAAACTAAACTATC ATCACACTACCTTGTATGCCAGCACCTGGTAACAGTAGAGATTTTTATACATTAATCTTGATCTGTTTTAATCTTGATCTGTTTTAGTAG AGATTTTTATACATTAATCTTGATCTGTTTTAATCTTGATCTGTTTTGTCCTAGAAAATTCCATCATACACACATTTCCTGATATTTGGG CTTAGTGCTTCTAAATTGTTGCAGACACAAAACTTAATGATTCATTCGTAGTAGTAATCTGTAGCTAGTTTTAGGGTTTTGCTGAAGTCA GTGTGGGGTGTTTGTTTGAGGAAAAAGTTCCAAATATCCACTAGCATAGAATTTTAAACTATTTTTATTTTAAAGTTATGGCATAACATA TAACATAAAAATATTTTATATACGTTTGAAAAATCTATACCGTTCTTTTTTATCATCAAAGTTTCTCAATGGCCAGTAGAAGCAAAAAGA CAACACCACCTCTGATCTACGGGACATAATGTTCCCAGGAAAAAAATCTTCAAGTGGGTGTGAGGGTGTTTCTAATTCAAAATATGTAGA TTTCTCCGCATGGAAGAAGTAGTAAAGATTTTCTTAACATGCTCCTGTGTTCATGCTTGGAGACAAGAATAAGATGGTTTAGAAGCTTTA CCCTTTCTTGGAACAAGTAGAATCCCGGTCTGAGACCTCTCAGGAATTTCAGAGCTTAGCAGTCTGGCCTGGAGGTTTTTCAGCCTTTTA GTATAATAAACAGTAGTTGCTTCCTAGAGTTGAGTTTTTAAGGATTCACAAAAAGGAGCCTGTACAAAATATACATACAGTTCTTTATTA AACAACTGTAAACACTTCACTGTAAAAATCCATAAAACTTTATAAACAAACATTTTGTAAATAGAATCTATGCTACAGTAAAATAATTAA CACAATTATTTACATGCAATACTGACAAATTTGGCACTTTTTGAAAAGAAATGTACAAAACACTTGCTTTAAAAGAAATTTAAAATTATA AAAACTCCGAGCATTACTATCATGCACTTTGCAAATACCTCACAAGCACTTATGGCACAGCTATCAGAGAGCATCAGGCTCTCTGGTAAT >54992_54992_1_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000338148_EIF5B_chr2_99980734_ENST00000289371_length(amino acids)=885AA_BP=0 MAGILRLVVQWPPGRLQTVTKGVESLICTDWIRHKFTRSRIPEKERLEQEKRERKKQKEKERKERLKKEGKLLTKSQREARARAEATLKL LQAQGVEVPSKDSLPKKRPIYEDKKRKKIPQQLESKEVSESMELCAAVEVMEQGVPEKEETPPPVEPEEEEDTEDAGLDDWEAMASDEET EKVEGNKVHIEVKENPEEEEEEEEEEEEDEESEEEEEEEGESEGSEGDEEDEKVSDEKDSGKTLDKKPSKEMSSDSEYDSDDDRTKEERA YDKAKRRIEKRRLEHSKNVNTEKLRAPIICVLGHVDTGKTKILDKLRHTHVQDGEAGGITQQIGATNVPLEAINEQTKMIKNFDRENVRI PGMLIIDTPGHESFSNLRNRGSSLCDIAILVVDIMHGLEPQTIESINLLKSKKCPFIVALNKIDRLYDWKKSPDSDVAATLKKQKKNTKD EFEERAKAIIVEFAQQGLNAALFYENKDPRTFVSLVPTSAHTGDGMGSLIYLLVELTQTMLSKRLAHCEELRAQVMEVKALPGMGTTIDV ILINGRLKEGDTIIVPGVEGPIVTQIRGLLLPPPMKELRVKNQYEKHKEVEAAQGVKILGKDLEKTLAGLPLLVAYKEDEIPVLKDELIH ELKQTLNAIKLEEKGVYVQASTLGSLEALLEFLKTSEVPYAGINIGPVHKKDVMKASVMLEHDPQYAVILAFDVRIERDAQEMADSLGVR IFSAEIIYHLFDAFTKYRQDYKKQKQEEFKHIAVFPCKIKILPQYIFNSRDPIVMGVTVEAGQVKQGTPMCVPSKNFVDIGIVTSIEINH -------------------------------------------------------------- >54992_54992_2_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000409145_EIF5B_chr2_99980734_ENST00000289371_length(transcript)=4661nt_BP=223nt AGTTCTTCCTCTGCTCTGCTTCCCTTCGGAGGAAAATTTCAGGCTGAAGGTTTAGCGGGTGCCGCCTCTAAAGAGAGCAATCACTACACT TATGGCTGGGATTTTGCGCTTAGTAGTTCAATGGCCCCCAGGCAGACTACAGACTGTGACAAAAGGTGTGGAGTCTCTTATTTGTACAGA TTGGATTCGTCACAAATTCACCAGATCAAGAATTCCAGAAAAAGAACGATTGGAACAAGAAAAAAGAGAAAGGAAAAAGCAAAAAGAAAA AGAAAGAAAAGAACGCTTGAAAAAAGAAGGGAAACTTTTAACTAAATCCCAGAGAGAAGCCAGAGCCAGAGCCGAAGCTACTCTTAAACT GCTACAAGCTCAGGGTGTTGAAGTGCCATCAAAAGACTCTTTGCCAAAGAAGAGGCCAATTTATGAAGATAAAAAGAGGAAAAAAATACC ACAGCAGCTAGAAAGTAAAGAAGTGTCTGAATCAATGGAATTATGTGCTGCTGTAGAAGTTATGGAACAAGGAGTACCAGAAAAGGAAGA GACACCACCTCCTGTTGAACCAGAAGAAGAAGAAGATACTGAGGATGCTGGATTGGATGATTGGGAAGCTATGGCCAGTGATGAGGAGAC AGAAAAAGTAGAAGGAAACAAAGTTCATATAGAAGTAAAAGAAAACCCTGAAGAGGAGGAGGAGGAGGAAGAAGAGGAAGAAGAAGATGA AGAAAGTGAAGAAGAGGAGGAAGAGGAGGGAGAAAGTGAAGGCAGTGAAGGTGATGAGGAAGATGAAAAGGTGTCAGATGAGAAGGATTC AGGGAAGACATTAGATAAAAAGCCAAGTAAAGAAATGAGCTCAGATTCTGAATATGACTCTGATGATGATCGGACTAAAGAAGAAAGGGC TTATGACAAAGCAAAACGGAGGATTGAGAAACGGCGACTTGAACATAGTAAAAATGTAAACACCGAAAAGCTAAGAGCCCCTATTATCTG CGTACTTGGGCATGTGGACACAGGGAAGACAAAAATTCTAGATAAGCTCCGTCACACACATGTACAAGATGGTGAAGCAGGTGGTATCAC ACAACAAATTGGGGCCACCAATGTTCCTCTTGAAGCTATTAATGAACAGACTAAGATGATTAAAAATTTTGATAGAGAGAATGTACGGAT TCCAGGAATGCTAATTATTGATACTCCTGGGCATGAATCTTTCAGTAATCTGAGAAATAGAGGAAGCTCTCTTTGTGACATTGCCATTTT AGTTGTTGATATTATGCATGGTTTGGAGCCCCAGACAATTGAGTCTATCAACCTTCTCAAATCTAAAAAATGTCCCTTCATTGTTGCACT CAATAAGATTGATAGGTTATATGATTGGAAAAAGAGTCCTGACTCTGATGTGGCTGCTACTTTAAAGAAGCAGAAAAAGAATACAAAAGA TGAATTTGAGGAGCGAGCAAAGGCTATTATTGTAGAATTTGCACAGCAGGGTTTGAATGCTGCTTTGTTTTATGAGAATAAAGATCCCCG CACTTTTGTGTCTTTGGTACCTACCTCTGCACATACTGGTGATGGCATGGGAAGTCTGATCTACCTTCTTGTAGAGTTAACTCAGACCAT GTTGAGCAAGAGACTTGCACACTGTGAAGAGCTGAGAGCACAGGTGATGGAGGTTAAAGCTCTCCCGGGGATGGGCACCACTATAGATGT CATCTTGATCAATGGGCGTTTGAAGGAAGGAGATACAATCATTGTTCCTGGAGTAGAAGGGCCCATTGTAACTCAGATTCGAGGCCTCCT GTTACCTCCTCCTATGAAGGAATTACGAGTGAAGAACCAGTATGAAAAGCATAAAGAAGTAGAAGCAGCTCAGGGGGTAAAGATTCTTGG AAAAGACCTGGAGAAAACATTGGCTGGTTTACCCCTCCTTGTGGCTTATAAAGAAGATGAAATCCCTGTTCTTAAAGATGAATTGATCCA TGAGTTAAAGCAGACACTAAATGCTATCAAATTAGAAGAAAAAGGAGTCTATGTCCAGGCATCTACACTGGGTTCTTTGGAAGCTCTACT GGAATTTCTGAAAACATCAGAAGTGCCCTATGCAGGAATTAACATTGGCCCAGTGCATAAAAAAGATGTTATGAAGGCTTCAGTGATGTT GGAACATGACCCTCAGTATGCAGTAATTTTGGCCTTCGATGTGAGAATTGAACGAGATGCACAAGAAATGGCTGATAGTTTAGGAGTTAG AATTTTTAGTGCAGAAATTATTTATCATTTATTTGATGCCTTTACAAAATATAGACAAGACTACAAGAAACAGAAACAAGAAGAATTTAA GCACATAGCAGTATTTCCCTGCAAGATAAAAATCCTCCCTCAGTACATTTTTAATTCTCGAGATCCGATAGTGATGGGGGTGACGGTGGA AGCAGGTCAGGTGAAACAGGGGACACCCATGTGTGTCCCAAGCAAAAATTTTGTTGACATCGGAATAGTAACAAGTATTGAAATAAACCA TAAACAAGTGGATGTTGCAAAAAAAGGACAAGAAGTTTGTGTAAAAATAGAACCTATCCCTGGTGAGTCACCCAAAATGTTTGGAAGACA TTTTGAAGCTACAGATATTCTTGTTAGTAAGATCAGCCGGCAGTCCATTGATGCACTCAAAGACTGGTTCAGAGATGAAATGCAGAAGAG TGACTGGCAGCTTATTGTGGAGCTGAAGAAAGTATTTGAAATCATCTAATTTTTTCACATGGAGCAGGAACTGGAGTAAATGCAATACTG TGTTGTAATATCCCAACAAAAATCAGACAAAAAATGGAACAGACGTATTTGGACACTGATGGACTTAAGTATGGAAGGAAGAAAAATAGG TGTATAAAATGTTTTCCATGAGAAACCAAGAAACTTACACTGGTTTGACAGTGGTCAGTTACATGTCCCCACAGTTCCAATGTGCCTGTT CACTCACCTCTCCCTTCCCCAACCCTTCTCTACTTGGCTGCTGTTTTAAAGTTTGCCCTTCCCCAAATTTGGATTTTTATTACAGATCTA AAGCTCTTTCGATTTTATACTGATTAAATCAGTACTGCAGTATTTGATTAACCAAGCTTCTGCAGATTTTGTGATTCTTGGGACTTTTTT GACGTAAGAAATACTTCTTTATTTATGCATATTCTTCCCACAGTGATTTTTCCAGCATTCTTCTGCCATATGCCTTTAGGGCTTTTATAA AATAGAAAATTAGGCATTCTGATATTTCTTTAGCTGCTTTGTGTGAAACCATGGTGTAAAAGCACAGCTGGCTGCTTTTTACTGCTTGTG TAGTCACGAGTCCATTGTAATCATCACAATTCTAAACCAAACTACCAATAAAGAAAACAGACATCCACCAGTAAGCAAGCTCTGTTAGGC TTCCATGTTAGTGTAGCTTCTCTCCCACAAGTTGTCCTCCTAGGACAAGAATTATCTTACAAACTAAACTATCATCACACTACCTTGTAT GCCAGCACCTGGTAACAGTAGAGATTTTTATACATTAATCTTGATCTGTTTTAATCTTGATCTGTTTTAGTAGAGATTTTTATACATTAA TCTTGATCTGTTTTAATCTTGATCTGTTTTGTCCTAGAAAATTCCATCATACACACATTTCCTGATATTTGGGCTTAGTGCTTCTAAATT GTTGCAGACACAAAACTTAATGATTCATTCGTAGTAGTAATCTGTAGCTAGTTTTAGGGTTTTGCTGAAGTCAGTGTGGGGTGTTTGTTT GAGGAAAAAGTTCCAAATATCCACTAGCATAGAATTTTAAACTATTTTTATTTTAAAGTTATGGCATAACATATAACATAAAAATATTTT ATATACGTTTGAAAAATCTATACCGTTCTTTTTTATCATCAAAGTTTCTCAATGGCCAGTAGAAGCAAAAAGACAACACCACCTCTGATC TACGGGACATAATGTTCCCAGGAAAAAAATCTTCAAGTGGGTGTGAGGGTGTTTCTAATTCAAAATATGTAGATTTCTCCGCATGGAAGA AGTAGTAAAGATTTTCTTAACATGCTCCTGTGTTCATGCTTGGAGACAAGAATAAGATGGTTTAGAAGCTTTACCCTTTCTTGGAACAAG TAGAATCCCGGTCTGAGACCTCTCAGGAATTTCAGAGCTTAGCAGTCTGGCCTGGAGGTTTTTCAGCCTTTTAGTATAATAAACAGTAGT TGCTTCCTAGAGTTGAGTTTTTAAGGATTCACAAAAAGGAGCCTGTACAAAATATACATACAGTTCTTTATTAAACAACTGTAAACACTT CACTGTAAAAATCCATAAAACTTTATAAACAAACATTTTGTAAATAGAATCTATGCTACAGTAAAATAATTAACACAATTATTTACATGC AATACTGACAAATTTGGCACTTTTTGAAAAGAAATGTACAAAACACTTGCTTTAAAAGAAATTTAAAATTATAAAAACTCCGAGCATTAC TATCATGCACTTTGCAAATACCTCACAAGCACTTATGGCACAGCTATCAGAGAGCATCAGGCTCTCTGGTAATATTTATGTAACTTTTAA >54992_54992_2_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000409145_EIF5B_chr2_99980734_ENST00000289371_length(amino acids)=885AA_BP=0 MAGILRLVVQWPPGRLQTVTKGVESLICTDWIRHKFTRSRIPEKERLEQEKRERKKQKEKERKERLKKEGKLLTKSQREARARAEATLKL LQAQGVEVPSKDSLPKKRPIYEDKKRKKIPQQLESKEVSESMELCAAVEVMEQGVPEKEETPPPVEPEEEEDTEDAGLDDWEAMASDEET EKVEGNKVHIEVKENPEEEEEEEEEEEEDEESEEEEEEEGESEGSEGDEEDEKVSDEKDSGKTLDKKPSKEMSSDSEYDSDDDRTKEERA YDKAKRRIEKRRLEHSKNVNTEKLRAPIICVLGHVDTGKTKILDKLRHTHVQDGEAGGITQQIGATNVPLEAINEQTKMIKNFDRENVRI PGMLIIDTPGHESFSNLRNRGSSLCDIAILVVDIMHGLEPQTIESINLLKSKKCPFIVALNKIDRLYDWKKSPDSDVAATLKKQKKNTKD EFEERAKAIIVEFAQQGLNAALFYENKDPRTFVSLVPTSAHTGDGMGSLIYLLVELTQTMLSKRLAHCEELRAQVMEVKALPGMGTTIDV ILINGRLKEGDTIIVPGVEGPIVTQIRGLLLPPPMKELRVKNQYEKHKEVEAAQGVKILGKDLEKTLAGLPLLVAYKEDEIPVLKDELIH ELKQTLNAIKLEEKGVYVQASTLGSLEALLEFLKTSEVPYAGINIGPVHKKDVMKASVMLEHDPQYAVILAFDVRIERDAQEMADSLGVR IFSAEIIYHLFDAFTKYRQDYKKQKQEEFKHIAVFPCKIKILPQYIFNSRDPIVMGVTVEAGQVKQGTPMCVPSKNFVDIGIVTSIEINH -------------------------------------------------------------- >54992_54992_3_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000410042_EIF5B_chr2_99980734_ENST00000289371_length(transcript)=4777nt_BP=339nt GCACTTTTCCAGCTCGAGCCCTCACGAGGCCGTGGGTACGACCGGAAGCCGCAGACTGAATCTCGCTCTGTTGCCCAGCCCATCTCGGCC CACTGAAACCTCCACCTCCCGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGAGATTACAGGCGCCTGCCACCACGCCCAG CCTCTAAAGAGAGCAATCACTACACTTATGGCTGGGATTTTGCGCTTAGTAGTTCAATGGCCCCCAGGCAGACTACAGACTGTGACAAAA GGTGTGGAGTCTCTTATTTGTACAGATTGGATTCGTCACAAATTCACCAGATCAAGAATTCCAGAAAAAGAACGATTGGAACAAGAAAAA AGAGAAAGGAAAAAGCAAAAAGAAAAAGAAAGAAAAGAACGCTTGAAAAAAGAAGGGAAACTTTTAACTAAATCCCAGAGAGAAGCCAGA GCCAGAGCCGAAGCTACTCTTAAACTGCTACAAGCTCAGGGTGTTGAAGTGCCATCAAAAGACTCTTTGCCAAAGAAGAGGCCAATTTAT GAAGATAAAAAGAGGAAAAAAATACCACAGCAGCTAGAAAGTAAAGAAGTGTCTGAATCAATGGAATTATGTGCTGCTGTAGAAGTTATG GAACAAGGAGTACCAGAAAAGGAAGAGACACCACCTCCTGTTGAACCAGAAGAAGAAGAAGATACTGAGGATGCTGGATTGGATGATTGG GAAGCTATGGCCAGTGATGAGGAGACAGAAAAAGTAGAAGGAAACAAAGTTCATATAGAAGTAAAAGAAAACCCTGAAGAGGAGGAGGAG GAGGAAGAAGAGGAAGAAGAAGATGAAGAAAGTGAAGAAGAGGAGGAAGAGGAGGGAGAAAGTGAAGGCAGTGAAGGTGATGAGGAAGAT GAAAAGGTGTCAGATGAGAAGGATTCAGGGAAGACATTAGATAAAAAGCCAAGTAAAGAAATGAGCTCAGATTCTGAATATGACTCTGAT GATGATCGGACTAAAGAAGAAAGGGCTTATGACAAAGCAAAACGGAGGATTGAGAAACGGCGACTTGAACATAGTAAAAATGTAAACACC GAAAAGCTAAGAGCCCCTATTATCTGCGTACTTGGGCATGTGGACACAGGGAAGACAAAAATTCTAGATAAGCTCCGTCACACACATGTA CAAGATGGTGAAGCAGGTGGTATCACACAACAAATTGGGGCCACCAATGTTCCTCTTGAAGCTATTAATGAACAGACTAAGATGATTAAA AATTTTGATAGAGAGAATGTACGGATTCCAGGAATGCTAATTATTGATACTCCTGGGCATGAATCTTTCAGTAATCTGAGAAATAGAGGA AGCTCTCTTTGTGACATTGCCATTTTAGTTGTTGATATTATGCATGGTTTGGAGCCCCAGACAATTGAGTCTATCAACCTTCTCAAATCT AAAAAATGTCCCTTCATTGTTGCACTCAATAAGATTGATAGGTTATATGATTGGAAAAAGAGTCCTGACTCTGATGTGGCTGCTACTTTA AAGAAGCAGAAAAAGAATACAAAAGATGAATTTGAGGAGCGAGCAAAGGCTATTATTGTAGAATTTGCACAGCAGGGTTTGAATGCTGCT TTGTTTTATGAGAATAAAGATCCCCGCACTTTTGTGTCTTTGGTACCTACCTCTGCACATACTGGTGATGGCATGGGAAGTCTGATCTAC CTTCTTGTAGAGTTAACTCAGACCATGTTGAGCAAGAGACTTGCACACTGTGAAGAGCTGAGAGCACAGGTGATGGAGGTTAAAGCTCTC CCGGGGATGGGCACCACTATAGATGTCATCTTGATCAATGGGCGTTTGAAGGAAGGAGATACAATCATTGTTCCTGGAGTAGAAGGGCCC ATTGTAACTCAGATTCGAGGCCTCCTGTTACCTCCTCCTATGAAGGAATTACGAGTGAAGAACCAGTATGAAAAGCATAAAGAAGTAGAA GCAGCTCAGGGGGTAAAGATTCTTGGAAAAGACCTGGAGAAAACATTGGCTGGTTTACCCCTCCTTGTGGCTTATAAAGAAGATGAAATC CCTGTTCTTAAAGATGAATTGATCCATGAGTTAAAGCAGACACTAAATGCTATCAAATTAGAAGAAAAAGGAGTCTATGTCCAGGCATCT ACACTGGGTTCTTTGGAAGCTCTACTGGAATTTCTGAAAACATCAGAAGTGCCCTATGCAGGAATTAACATTGGCCCAGTGCATAAAAAA GATGTTATGAAGGCTTCAGTGATGTTGGAACATGACCCTCAGTATGCAGTAATTTTGGCCTTCGATGTGAGAATTGAACGAGATGCACAA GAAATGGCTGATAGTTTAGGAGTTAGAATTTTTAGTGCAGAAATTATTTATCATTTATTTGATGCCTTTACAAAATATAGACAAGACTAC AAGAAACAGAAACAAGAAGAATTTAAGCACATAGCAGTATTTCCCTGCAAGATAAAAATCCTCCCTCAGTACATTTTTAATTCTCGAGAT CCGATAGTGATGGGGGTGACGGTGGAAGCAGGTCAGGTGAAACAGGGGACACCCATGTGTGTCCCAAGCAAAAATTTTGTTGACATCGGA ATAGTAACAAGTATTGAAATAAACCATAAACAAGTGGATGTTGCAAAAAAAGGACAAGAAGTTTGTGTAAAAATAGAACCTATCCCTGGT GAGTCACCCAAAATGTTTGGAAGACATTTTGAAGCTACAGATATTCTTGTTAGTAAGATCAGCCGGCAGTCCATTGATGCACTCAAAGAC TGGTTCAGAGATGAAATGCAGAAGAGTGACTGGCAGCTTATTGTGGAGCTGAAGAAAGTATTTGAAATCATCTAATTTTTTCACATGGAG CAGGAACTGGAGTAAATGCAATACTGTGTTGTAATATCCCAACAAAAATCAGACAAAAAATGGAACAGACGTATTTGGACACTGATGGAC TTAAGTATGGAAGGAAGAAAAATAGGTGTATAAAATGTTTTCCATGAGAAACCAAGAAACTTACACTGGTTTGACAGTGGTCAGTTACAT GTCCCCACAGTTCCAATGTGCCTGTTCACTCACCTCTCCCTTCCCCAACCCTTCTCTACTTGGCTGCTGTTTTAAAGTTTGCCCTTCCCC AAATTTGGATTTTTATTACAGATCTAAAGCTCTTTCGATTTTATACTGATTAAATCAGTACTGCAGTATTTGATTAACCAAGCTTCTGCA GATTTTGTGATTCTTGGGACTTTTTTGACGTAAGAAATACTTCTTTATTTATGCATATTCTTCCCACAGTGATTTTTCCAGCATTCTTCT GCCATATGCCTTTAGGGCTTTTATAAAATAGAAAATTAGGCATTCTGATATTTCTTTAGCTGCTTTGTGTGAAACCATGGTGTAAAAGCA CAGCTGGCTGCTTTTTACTGCTTGTGTAGTCACGAGTCCATTGTAATCATCACAATTCTAAACCAAACTACCAATAAAGAAAACAGACAT CCACCAGTAAGCAAGCTCTGTTAGGCTTCCATGTTAGTGTAGCTTCTCTCCCACAAGTTGTCCTCCTAGGACAAGAATTATCTTACAAAC TAAACTATCATCACACTACCTTGTATGCCAGCACCTGGTAACAGTAGAGATTTTTATACATTAATCTTGATCTGTTTTAATCTTGATCTG TTTTAGTAGAGATTTTTATACATTAATCTTGATCTGTTTTAATCTTGATCTGTTTTGTCCTAGAAAATTCCATCATACACACATTTCCTG ATATTTGGGCTTAGTGCTTCTAAATTGTTGCAGACACAAAACTTAATGATTCATTCGTAGTAGTAATCTGTAGCTAGTTTTAGGGTTTTG CTGAAGTCAGTGTGGGGTGTTTGTTTGAGGAAAAAGTTCCAAATATCCACTAGCATAGAATTTTAAACTATTTTTATTTTAAAGTTATGG CATAACATATAACATAAAAATATTTTATATACGTTTGAAAAATCTATACCGTTCTTTTTTATCATCAAAGTTTCTCAATGGCCAGTAGAA GCAAAAAGACAACACCACCTCTGATCTACGGGACATAATGTTCCCAGGAAAAAAATCTTCAAGTGGGTGTGAGGGTGTTTCTAATTCAAA ATATGTAGATTTCTCCGCATGGAAGAAGTAGTAAAGATTTTCTTAACATGCTCCTGTGTTCATGCTTGGAGACAAGAATAAGATGGTTTA GAAGCTTTACCCTTTCTTGGAACAAGTAGAATCCCGGTCTGAGACCTCTCAGGAATTTCAGAGCTTAGCAGTCTGGCCTGGAGGTTTTTC AGCCTTTTAGTATAATAAACAGTAGTTGCTTCCTAGAGTTGAGTTTTTAAGGATTCACAAAAAGGAGCCTGTACAAAATATACATACAGT TCTTTATTAAACAACTGTAAACACTTCACTGTAAAAATCCATAAAACTTTATAAACAAACATTTTGTAAATAGAATCTATGCTACAGTAA AATAATTAACACAATTATTTACATGCAATACTGACAAATTTGGCACTTTTTGAAAAGAAATGTACAAAACACTTGCTTTAAAAGAAATTT AAAATTATAAAAACTCCGAGCATTACTATCATGCACTTTGCAAATACCTCACAAGCACTTATGGCACAGCTATCAGAGAGCATCAGGCTC TCTGGTAATATTTATGTAACTTTTAATGTGCTTCCATAAGTTTGTTGTAAAACCACCTGGACATTGTCAAGAATAAAGTCAAATGCCATA >54992_54992_3_MRPL30-EIF5B_MRPL30_chr2_99804720_ENST00000410042_EIF5B_chr2_99980734_ENST00000289371_length(amino acids)=885AA_BP=0 MAGILRLVVQWPPGRLQTVTKGVESLICTDWIRHKFTRSRIPEKERLEQEKRERKKQKEKERKERLKKEGKLLTKSQREARARAEATLKL LQAQGVEVPSKDSLPKKRPIYEDKKRKKIPQQLESKEVSESMELCAAVEVMEQGVPEKEETPPPVEPEEEEDTEDAGLDDWEAMASDEET EKVEGNKVHIEVKENPEEEEEEEEEEEEDEESEEEEEEEGESEGSEGDEEDEKVSDEKDSGKTLDKKPSKEMSSDSEYDSDDDRTKEERA YDKAKRRIEKRRLEHSKNVNTEKLRAPIICVLGHVDTGKTKILDKLRHTHVQDGEAGGITQQIGATNVPLEAINEQTKMIKNFDRENVRI PGMLIIDTPGHESFSNLRNRGSSLCDIAILVVDIMHGLEPQTIESINLLKSKKCPFIVALNKIDRLYDWKKSPDSDVAATLKKQKKNTKD EFEERAKAIIVEFAQQGLNAALFYENKDPRTFVSLVPTSAHTGDGMGSLIYLLVELTQTMLSKRLAHCEELRAQVMEVKALPGMGTTIDV ILINGRLKEGDTIIVPGVEGPIVTQIRGLLLPPPMKELRVKNQYEKHKEVEAAQGVKILGKDLEKTLAGLPLLVAYKEDEIPVLKDELIH ELKQTLNAIKLEEKGVYVQASTLGSLEALLEFLKTSEVPYAGINIGPVHKKDVMKASVMLEHDPQYAVILAFDVRIERDAQEMADSLGVR IFSAEIIYHLFDAFTKYRQDYKKQKQEEFKHIAVFPCKIKILPQYIFNSRDPIVMGVTVEAGQVKQGTPMCVPSKNFVDIGIVTSIEINH -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for MRPL30-EIF5B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MRPL30-EIF5B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for MRPL30-EIF5B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies